coronavirus vaccine

Stories 761 - 780 | << Prev   Next >>

Pfizer CEO Sold Big Chunk of Shares on Day of Vaccine News

He sold $5.6M in shares as price soared

(Newser) - Pfizer CEO Albert Bourla sold a big chunk of his shares on the same day the company announced very promising news on a coronavirus vaccine , according to an SEC filing. Bourla sold shares worth $5.6 million as the company's stock price soared on Monday, but the company says...

Russia: Our Sputnik V Vaccine Works
Russia:
Our Sputnik V
Vaccine Works
Nov 11, 2020 8:38 AM CST

Russia: Our Sputnik V Vaccine Works

Says it shows 92% efficacy against the coronavirus

(Newser) - In a dramatic first among nations , Russia approved its Sputnik V coronavirus vaccine in August. Two months later, the country is sharing data that it says points to the vaccine's effectiveness. The Wall Street Journal reports interim results from the 40,000-person Phase 3 trial that is underway have...

Brazil Halts Vaccine Trial After 'Serious Incident'

Bolsonaro calls CoronaVac move a 'victory'

(Newser) - Brazil's health regulator has halted clinical trials of the potential coronavirus vaccine CoronaVac, citing an "adverse, serious event." Adversaries of President Jair Bolsonaro said they feared the decision was motivated not by science but by the leader's political hostility to the country and state involved in...

What Fauci Thinks About Pfizer Vaccine

'Extraordinary,' he says, and explains why the news is doubly good

(Newser) - Anthony Fauci isn't mincing words when it comes to the coronavirus vaccine Pfizer has on the horizon . "The results are really quite good, I mean extraordinary," said the director of the National Institute of Allergy and Infectious Diseases. He added that that might also be good news...

&#39;Dream Team&#39; Couple Are Behind New Vaccine
'Dream Team' Couple Helped
Develop New Vaccine
THE RUNDOWN
Nov 9, 2020 3:23 PM CST

'Dream Team' Couple Helped Develop New Vaccine

Huge challenges will await after approval

(Newser) - The exhilarating news that a COVID-19 vaccine was a big success in a large-scale trial is a victory for Pfizer—and for the husband-and-wife team behind BioNTech, the German biotech firm that collaborated with the American drugmaker. CEO Ugur Sahin and his wife, board member Oezlem Tuereci, founded the firm...

Donald Trump Jr. Thinks Vaccine News Is a Little Fishy

He suggests Pfizer delayed news to benefit Joe Biden

(Newser) - Pfizer's announcement that its vaccine appears to deliver strong protection against COVID-19 was hailed as great news in the stock market and beyond. But Donald Trump Jr. sees a political conspiracy at play, suggesting that the company held off on the news to hurt his father's reelection chances,...

Dow Smashes Record, but Zoom Is Hurting

All this after Pfizer reported hopeful news on a vaccine

(Newser) - The futures traders were right : The Dow came out of the gate on fire Monday, soaring more than 1,500 points at the open to an all-time high, reports CNBC . The great start comes after Pfizer announced that its COVID vaccine looks to be 90% effective in early results. At...

Pfizer Reports Big News on Early Vaccine Results

Preliminary data shows it's 90% effective

(Newser) - Pfizer says early data suggest its COVID vaccine works—in a big way. The company said Monday that its vaccine appears to be 90% effective in preventing infections, without serious side effects, reports the New York Times . A big qualification: These are early results, and the numbers could drop as...

Feds Scrap Plan for Santa to Promote Vaccine

Santas, helpers would have received vaccine early

(Newser) - Santa and his helpers will no longer be among the first in line for a coronavirus vaccine. The Department of Health and Human Services has scrapped a plan to have Santa Clauses in dozens of cities promote the benefits of vaccination in return for early access to a vaccine, the...

Vaccine Candidate Has Good News for Seniors

Candidate from AstraZeneca and Oxford sees immune response, few side effects in older adults

(Newser) - Bad news about COVID is easy to find these days, whether in the US or overseas . But now comes a dose of good news from the makers of one of the leading vaccine candidates. AstraZeneca, which is teaming with Oxford University, said Monday that its vaccine produces an immune response...

New COVID Trials Will Be 'a Little Different From Most'

'Human challenge' studies in the UK will involve deliberately injecting healthy subjects with virus

(Newser) - Clinical trials for a COVID-19 vaccine are currently in their final stages via a number of drug companies, but a new set soon to begin in the UK promises to be "a little different from most." CNN reports the British government has signed a contract for the first...

Pfizer's Update on Vaccine Is a 'Shift in Tone'

Announcement on application for emergency authorization predicts late November at the earliest

(Newser) - Last month, President Trump hinted that a COVID-19 vaccine could be available before Election Day, but the latest news from one of the leading developers seems to make that possibility even more remote. As the Wall Street Journal reports, Pfizer CEO Albert Bourla posted an open letter Friday announcing that,...

&#39;Gloomy&#39; Pandemic Reporter: I Can Finally See Hope
'Gloomy' COVID Reporter
Has a Change of Heart 
OPINION
Oct 13, 2020 11:42 AM CDT

'Gloomy' COVID Reporter Has a Change of Heart

Donald G. McNeil Jr. is 'cautiously optimistic' about what lies ahead

(Newser) - Since January, New York Times health reporter Donald G. McNeil Jr. has been covering the pandemic, including American deaths and efforts to develop a vaccine years ahead of the fastest pace on record. All this has made him "a consistently gloomy Cassandra"—but halfway through October, he's...

'Unexplained Illness' Halts Another Vaccine Trial

This time it's Johnson & Johnson

(Newser) - Once again, a coronavirus vaccine trial has been temporarily halted due to an unexplained illness in one of the study participants. This time, it's Johnson & Johnson's trial that's on pause; the company says in a statement that clinical studies are expected to have adverse events, but...

China Joins Vaccine Alliance
China Joins Vaccine Alliance
Oct 9, 2020 12:01 AM CDT

China Joins Vaccine Alliance

Country initially resisted joining COVAX effort

(Newser) - China, which has at least four coronavirus vaccine candidates in the last stage of clinical trials, said Friday it is joining the COVID-19 vaccine alliance known as COVAX. The country signed an agreement with the Gavi organization, the co-leader of the alliance, on Thursday, China's Foreign Ministry said in...

Trump: FDA Vaccine Rules Are a 'Political Hit Job'

With 2-month observation period, pre-election authorization is unlikely

(Newser) - The Trump administration has signed off on FDA guidelines for a thorough coronavirus vaccine review, which is likely to delay authorization until after Election Day, per the Wall Street Journal . Though officials had initially blocked the guidelines, per the AP , a senior administration official tells the Journal that the White...

Seattle Patient Has Second COVID Infection

Case is only the third confirmed in the world

(Newser) - For only the third time worldwide, a COVID-19 survivor has come down with a second infection of the coronavirus. The person, who is in their 60s, was hospitalized after the first infection, then was living in a nursing facility, KIRO reports. More than four months later, the patient developed mild...

Moderna Updates Its Coronavirus Vaccine Timeline

Not the kind of update you want to hear

(Newser) - Moderna has updated the world on the timeline for its coronavirus vaccine, and as far as the general population is concerned, we're looking at spring. CBS News reports that on Wednesday, CEO Stephane Bancel said the soonest the company might seek emergency authorization for the vaccine, which would give...

Cuomo Makes Big Move on Vaccine
Cuomo Makes
Big Move
on Vaccine
Sep 24, 2020 1:57 PM CDT

Cuomo Makes Big Move on Vaccine

New York governor will form panel to vet anything pushed by federal government

(Newser) - When the federal government gives the green light for the first COVID vaccine, New Yorkers may be waiting longer than others. Gov. Andrew Cuomo on Thursday said he was forming a special panel of experts to vet anything approved by the feds before it gets distributed in his state, reports...

Johnson & Johnson Starts a Notable Vaccine Trial

Its Phase 3 trial is to be the biggest, and it's testing a single-dose vaccine

(Newser) - Johnson & Johnson on Monday started Phase 3 trials of its coronavirus vaccine, something three of its big US competitors have already done. But the New York Times points out that Johnson & Johnson's candidate is an appealing one, in that it may end up being a single-dose vaccine....

Stories 761 - 780 | << Prev   Next >>
Most Read on Newser